1. Product Overview
2. Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
Global Oncology Drugs Market Outlook
5.1. Market Size &
Forecast
5.1.1.
By Value
5.2. Market Share &
Forecast
5.2.1.
By Drug Type (Cytotoxic Drugs, Targeted Drugs,
Hormonal Drugs)
5.2.2.
By Therapy (Chemotherapy, Targeted Therapy,
Immunotherapy (Biologic Therapy), Hormonal Therapy, Others)
5.2.3.
By Drug Therapy (Adjuvant, Neoadjuvant and
Concurrent)
5.2.4.
By Route of Administration (Oral, Intravenous,
Subcutaneous, Others)
5.2.5.
By Gender (Male, Female)
5.2.6.
By Cancer Type (Lung Cancer, Stomach Cancer,
Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus
Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others)
5.2.7.
By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Online Pharmacies, Government Hospitals)
5.2.8.
By Company (2019)
5.2.9.
By Region
5.3.
Market Attractiveness Index
6.
Asia-Pacific Oncology Drugs Market Outlook
6.1. Market Size &
Forecast
6.1.1.
By Value
6.2. Market Share &
Forecast
6.2.1.
By Drug Type
6.2.2.
By Therapy
6.2.3.
By Drug Therapy
6.2.4.
By Route of Administration
6.2.5.
By Gender
6.2.6.
By Cancer Type
6.2.7.
By Country
6.3. Asia-Pacific: Country
Analysis
6.3.1.
China Oncology Drugs Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Type
6.3.1.2.2.
By Therapy
6.3.1.2.3.
By Drug Therapy
6.3.1.2.4.
By Route of Administration
6.3.1.2.5.
By Gender
6.3.1.2.6.
By Cancer Type
6.3.2.
India Oncology Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Type
6.3.2.2.2.
By Therapy
6.3.2.2.3.
By Drug Therapy
6.3.2.2.4.
By Route of Administration
6.3.2.2.5.
By Gender
6.3.2.2.6.
By Cancer Type
6.3.3.
Japan Oncology Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Type
6.3.3.2.2.
By Therapy
6.3.3.2.3.
By Drug Therapy
6.3.3.2.4.
By Route of Administration
6.3.3.2.5.
By Gender
6.3.3.2.6.
By Cancer Type
6.3.4.
South Korea Oncology Drugs Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug Type
6.3.4.2.2.
By Therapy
6.3.4.2.3.
By Drug Therapy
6.3.4.2.4.
By Route of Administration
6.3.4.2.5.
By Gender
6.3.4.2.6.
By Cancer Type
6.3.5.
Singapore Oncology Drugs Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug Type
6.3.5.2.2.
By Therapy
6.3.5.2.3.
By Drug Therapy
6.3.5.2.4.
By Route of Administration
6.3.5.2.5.
By Gender
6.3.5.2.6.
By Cancer Type
6.3.6.
Australia Oncology Drugs Market Outlook
6.3.6.1.
Market Size & Forecast
6.3.6.1.1.
By Value
6.3.6.2.
Market Share & Forecast
6.3.6.2.1.
By Drug Type
6.3.6.2.2.
By Therapy
6.3.6.2.3.
By Drug Therapy
6.3.6.2.4.
By Route of Administration
6.3.6.2.5.
By Gender
6.3.6.2.6.
By Cancer Type
7.
Europe Oncology Drugs Market Outlook
7.1. Market Size &
Forecast
7.1.1.
By Value
7.2. Market Share &
Forecast
7.2.1.
By Drug Type
7.2.2.
By Therapy
7.2.3.
By Drug Therapy
7.2.4.
By Route of Administration
7.2.5.
By Gender
7.2.6.
By Cancer Type
7.2.7.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Oncology Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Type
7.3.1.2.2.
By Therapy
7.3.1.2.3.
By Drug Therapy
7.3.1.2.4.
By Route of Administration
7.3.1.2.5.
By Gender
7.3.1.2.6.
By Cancer Type
7.3.2.
Germany Oncology Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Type
7.3.2.2.2.
By Therapy
7.3.2.2.3.
By Drug Therapy
7.3.2.2.4.
By Route of Administration
7.3.2.2.5.
By Gender
7.3.2.2.6.
By Cancer Type
7.3.3.
United Kingdom Oncology Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Type
7.3.3.2.2.
By Therapy
7.3.3.2.3.
By Drug Therapy
7.3.3.2.4.
By Route of Administration
7.3.3.2.5.
By Gender
7.3.3.2.6.
By Cancer Type
7.3.4.
Italy Oncology Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Type
7.3.4.2.2.
By Therapy
7.3.4.2.3.
By Drug Therapy
7.3.4.2.4.
By Route of Administration
7.3.4.2.5.
By Gender
7.3.4.2.6.
By Cancer Type
7.3.5.
Spain Oncology Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Type
7.3.5.2.2.
By Therapy
7.3.5.2.3.
By Drug Therapy
7.3.5.2.4.
By Route of Administration
7.3.5.2.5.
By Gender
7.3.5.2.6.
By Cancer Type
8.
North America Oncology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share &
Forecast
8.2.1.
By Drug Type
8.2.2.
By Therapy
8.2.3.
By Drug Therapy
8.2.4.
By Route of Administration
8.2.5.
By Gender
8.2.6.
By Cancer Type
8.2.7.
By Country
8.3. North America: Country
Analysis
8.3.1.
United States Oncology Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Type
8.3.1.2.2.
By Therapy
8.3.1.2.3.
By Drug Therapy
8.3.1.2.4.
By Route of Administration
8.3.1.2.5.
By Gender
8.3.1.2.6.
By Cancer Type
8.3.2.
Mexico Oncology Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Type
8.3.2.2.2.
By Therapy
8.3.2.2.3.
By Drug Therapy
8.3.2.2.4.
By Route of Administration
8.3.2.2.5.
By Gender
8.3.2.2.6.
By Cancer Type
8.3.3.
Canada Oncology Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Type
8.3.3.2.2.
By Therapy
8.3.3.2.3.
By Drug Therapy
8.3.3.2.4.
By Route of Administration
8.3.3.2.5.
By Gender
8.3.3.2.6.
By Cancer Type
9.
South America Oncology Drugs Market Outlook
9.1. Market Size &
Forecast
9.1.1.
By Value
9.2. Market Share &
Forecast
9.2.1.
By Drug Type
9.2.2.
By Therapy
9.2.3.
By Drug Therapy
9.2.4.
By Route of Administration
9.2.5.
By Gender
9.2.6.
By Cancer Type
9.2.7.
By Country
9.3. South America: Country
Analysis
9.3.1.
Brazil Oncology Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Type
9.3.1.2.2.
By Therapy
9.3.1.2.3.
By Drug Therapy
9.3.1.2.4.
By Route of Administration
9.3.1.2.5.
By Gender
9.3.1.2.6.
By Cancer Type
9.3.2.
Argentina Oncology Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Type
9.3.2.2.2.
By Therapy
9.3.2.2.3.
By Drug Therapy
9.3.2.2.4.
By Route of Administration
9.3.2.2.5.
By Gender
9.3.2.2.6.
By Cancer Type
9.3.3.
Colombia Oncology Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Type
9.3.3.2.2.
By Therapy
9.3.3.2.3.
By Drug Therapy
9.3.3.2.4.
By Route of Administration
9.3.3.2.5.
By Gender
9.3.3.2.6.
By Cancer Type
10.
Middle East and Africa Oncology Drugs
Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.
By Drug Type
10.2.2.
By Therapy
10.2.3.
By Drug Therapy
10.2.4.
By Route of Administration
10.2.5.
By Gender
10.2.6.
By Cancer Type
10.2.7. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Oncology
Drugs Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Drug Type
10.3.1.2.2.
By Therapy
10.3.1.2.3.
By Drug Therapy
10.3.1.2.4.
By Route of Administration
10.3.1.2.5.
By Gender
10.3.1.2.6.
By Cancer Type
10.3.2. Saudi Arabia Oncology
Drugs Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Drug Type
10.3.2.2.2.
By Therapy
10.3.2.2.3.
By Drug Therapy
10.3.2.2.4.
By Route of Administration
10.3.2.2.5.
By Gender
10.3.2.2.6.
By Cancer Type
10.3.3. UAE Oncology Drugs
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Drug Type
10.3.3.2.2.
By Therapy
10.3.3.2.3.
By Drug Therapy
10.3.3.2.4.
By Route of Administration
10.3.3.2.5.
By Gender
10.3.3.2.6.
By Cancer Type
10.3.4. Kuwait Oncology Drugs
Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Drug Type
10.3.4.2.2.
By Therapy
10.3.4.2.3.
By Drug Therapy
10.3.4.2.4.
By Route of Administration
10.3.4.2.5.
By Gender
10.3.4.2.6.
By Cancer Type
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Patents (NDA, ANDA)
13. Market Trends &
Developments
14. Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1.
AbbVie Inc
14.2.2.
Roche Holding AG
14.2.3.
Novartis International AG
14.2.4.
Johnson & Johnson
14.2.5.
Bristol-Myers Squibb Company